-
A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
NCT07348237 ·
Phase: Phase 1 ·
Ages: 24 Years to 85 Years ·
Sex: All (male and female)
· Florida: Miami Lakes, Orlando
-
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
NCT06830629 ·
Phase: Phase 2 ·
Ages: 18 Years to 68 Years ·
Sex: All (male and female)
· Florida: Atlantis, Brandon, Hollywood, Melbourne
-
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Boca Raton, Boynton Beach, Edgewater, Fort Lauderdale
-
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
NCT07662135 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Fleming Island, Lauderdale Lakes, Leesburg, Miami Lakes
-
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
NCT07222917 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Hollywood, Port Charlotte, Port Orange
-
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
NCT06717698 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Fleming Island, Hollywood, Saint Augustine, Winter Haven
-
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
NCT07268638 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Boca Raton, Coral Springs, Hialeah, Miami
-
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
NCT06933472 ·
Phase: Phase 3 ·
Ages: 12 Years and older ·
Sex: All (male and female)
· Florida: Fort Myers
-
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
NCT07559396 ·
Phase: Phase 1 ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female)
· Florida: Miami Lakes, Orlando
-
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
NCT06749457 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female)
· Florida: Bradenton, Coral Springs, Hollywood, Orlando
-
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Fort Myers
-
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
NCT03619850 ·
Phase: Phase 3 ·
Ages: 2 Years to 17 Years ·
Sex: All (male and female)
· Florida: Hollywood
-
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
NCT04671771 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 90 Years ·
Sex: All (male and female)
· Florida: Sarasota, Tampa
-
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
NCT07107945 ·
Phase: Phase 3 ·
Ages: 2 Years to 17 Years ·
Sex: All (male and female)
· Florida: Miami
-
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Boca Raton, Boynton Beach, Cutler Bay, Fort Lauderdale
-
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
NCT06721143 ·
Phase: Phase 1, Phase 2 ·
Ages: 35 Years to 75 Years ·
Sex: All (male and female)
· Florida: Miami
-
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
NCT05457283 ·
Phase: Phase 3 ·
Ages: 1 Year to 18 Years ·
Sex: All (male and female)
· Florida: Hollywood
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
NCT04392206 ·
Phase: Phase 1 ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female)
· Florida: Jacksonville
-
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
NCT07572890 ·
Phase: Phase 1 ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Florida: Winter Park
-
BLOOM: Biological Legacy of Origin in Mother-Infant Dyads
NCT02000895 ·
Phase: Not specified ·
Ages: Up to 10 Years ·
Sex: All (male and female)
· Florida: Miami
-
Breakthrough - T1DM and Chronic Kidney Disease
NCT07592000 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· Florida: Miami
-
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
NCT05931276 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Gainesville
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·
Phase: Not specified ·
Ages: 40 Years to 75 Years ·
Sex: All (male and female)
· Florida: Aventura, Bonita Springs, Clearwater, Deerfield Beach
-
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961 ·
Phase: Phase 2, Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Boca Raton, Bradenton, Brooksville, Coral Gables
-
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Boca Raton, Gainesville, Jacksonville Beach, Miami
-
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
NCT06712407 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Boca Raton, Orlando
-
Ferric Citrate and Chronic Kidney Disease in Children
NCT04741646 ·
Phase: Phase 2 ·
Ages: 6 Years to 18 Years ·
Sex: All (male and female)
· Florida: Orlando
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
NCT06906640 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: St. Petersburg
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NCT06906627 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: St. Petersburg
-
Incremental Hemodialysis: The TwoPlus Trial
NCT05828823 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Jacksonville
-
Lumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology
NCT06077747 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Jacksonville
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
NCT06190717 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 84 Years ·
Sex: All (male and female)
· Florida: Orlando
-
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319 ·
Phase: Phase 3 ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Florida: Orlando
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
NCT06422871 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Sarasota
-
Pivotal Study of the Velocity™ pAVF System
NCT07153939 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Florida: Cocoa, Jacksonville
-
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
NCT06516653 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Florida: Sarasota
-
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT04634916 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Jacksonville, Lakeland, Miami
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
NCT06001827 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Tallahassee
-
SAfety of Regional Citrate Anticoagulation (SARCA Study)
NCT05339139 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Orlando
-
SPYRAL GEMINI Pilot Study
NCT06907147 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Florida: Orlando, Safety Harbor
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
NCT06752577 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Jacksonville
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
NCT07235059 ·
Phase: Phase 1 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female)
· Florida: Miami
-
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
NCT06217302 ·
Phase: Phase 3 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· Florida: Orlando
-
Study of BHV-1400 in IgA Nephropathy
NCT07054684 ·
Phase: Phase 1 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female)
· Florida: Miami Lakes, Orlando, Pembroke Pines
-
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
NCT07271186 ·
Phase: Phase 2 ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Florida: Doral, Hialeah, Hollywood, Margate